Phase I/II study of oncolytic herpes simplex virus NV1020 in patients with extensively pretreated refractory colorectal cancer metastatic to the liver
Geevarghese, Sunil K, Geller, David A, de Haan, Hans A, Hörer, Markus, Knoll, Anette E, Mescheder, Axel, Nemunaitis, John, Reid, Tony R, Sze, Daniel Y, Tanabe, Kenneth K, Tawfik, Hoda
Published in Human gene therapy (01.09.2010)
Published in Human gene therapy (01.09.2010)
Get more information
Journal Article
Response to intra-arterial oncolytic virotherapy with the herpes virus NV1020 evaluated by [18F]fluorodeoxyglucose positron emission tomography and computed tomography
Sze, Daniel Y, Iagaru, Andrei H, Gambhir, Sanjiv S, De Haan, Hans A, Reid, Tony R
Published in Human gene therapy (01.01.2012)
Published in Human gene therapy (01.01.2012)
Get more information
Journal Article
Reduction in circulating dsDNA antibody titer after administration of LJP 394
Weisman, M H, Bluestein, H G, Berner, C M, de Haan, H A
Published in Journal of rheumatology (01.02.1997)
Get more information
Published in Journal of rheumatology (01.02.1997)
Journal Article
Treatment of systemic lupus erythematosus with LJP 394
Furie, R A, Cash, J M, Cronin, M E, Katz, R S, Weisman, M H, Aranow, C, Liebling, M R, Hudson, N P, Berner, C M, Coutts, S, de Haan, H A
Published in Journal of rheumatology (01.02.2001)
Get more information
Published in Journal of rheumatology (01.02.2001)
Journal Article